These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 1893016)
1. [Spread pattern of HIV-2 in patients at risk. Evaluation of serologic markers]. Ollero M; Pujol E; Márquez P; Gimeno A; Alcoucer R; Mora D An Med Interna; 1991 Mar; 8(3):116-21. PubMed ID: 1893016 [TBL] [Abstract][Full Text] [Related]
2. Predominance of HIV-1 among patients with AIDS and AIDS-related complex in Ghana. Brandful JA; Ampofo WK; Apeagyei FA; Asare-Bediako K; Osei-Kwasi M East Afr Med J; 1997 Jan; 74(1):17-20. PubMed ID: 9145571 [TBL] [Abstract][Full Text] [Related]
3. [A multicenter study of infection with human immunodeficiency virus type-2 (HIV-2) in Spain (1991). The Spanish Group for the Study of HIV-2]. Soriano V; Gutiérrez M; Tuset C; Martínez-Zapico R; Ortiz de Lejarazu R; Aguilera A; Codina G; González A; Ulloa F; Leal M Med Clin (Barc); 1993 Apr; 100(14):531-5. PubMed ID: 8469039 [TBL] [Abstract][Full Text] [Related]
4. [HTLV-I infection in a high-risk group]. Pujol E; Ollero M; Gimeno A; Colchero J; Alcoucer R; Márquez P An Med Interna; 1990 Jul; 7(7):349-52. PubMed ID: 2103246 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of various criteria for the interpretation of western blot for the diagnosis of human immunodeficiency virus infection. Spanish Group for the Study of HIV-2]. Soriano V; Concheiro Carro L; Gutiérrez M; Tuset C; Martínez-Zapico R; Ortiz de Lejarazu R; González A; Aguilera A; Codina G; Ulloa F Med Clin (Barc); 1993 Apr; 100(15):561-6. PubMed ID: 8497143 [TBL] [Abstract][Full Text] [Related]
6. [Analysis of new criteria for increasing the specificity of commercial Western blots]. Gershy-Damet GM; Koffi K; Soro B; Sanon S; Traore M; Assoa A; N'Goran K; N'Gom A Bull Soc Pathol Exot; 1992; 85(5):338-41. PubMed ID: 1292790 [TBL] [Abstract][Full Text] [Related]
7. [HTLV-I infection in sailors who travel to sub-Saharan West Africa]. Pujol E; Ollero M; Márquez P; Gea A; Alcoucer R; Gimeno A Enferm Infecc Microbiol Clin; 1991 May; 9(5):283-5. PubMed ID: 1954264 [TBL] [Abstract][Full Text] [Related]
8. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices. Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471 [TBL] [Abstract][Full Text] [Related]
9. Incidence of dual presence of antibodies to HIV1 and HIV2 in seropositive cases seen in Ibadan, Nigeria. Shokunbi WA; Saliu I; Essien EM Afr J Med Med Sci; 1995 Sep; 24(3):249-53. PubMed ID: 8798960 [TBL] [Abstract][Full Text] [Related]
10. Risk factor analysis and serological diagnosis of HIV-1/HIV-2 infection in a Brazilian blood donor population: validation of the World Health Organization strategy for HIV testing. Carvalho MB; Hamerschlak N; Vaz RS; Ferreira OC AIDS; 1996 Sep; 10(10):1135-40. PubMed ID: 8874631 [TBL] [Abstract][Full Text] [Related]
11. HIV antibodies among intravenous drug users in Bahrain. al-Haddad MK; Khashaba AS; Baig BZ; Khalfan S J Commun Dis; 1994 Sep; 26(3):127-32. PubMed ID: 7868834 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of an expanded two-ELISA approach for confirmation of reactive serum samples in an HIV-screening programme for pregnant women. Van Doornum GJ; Buimer M; Gobbers E; Bindels PJ; Coutinho RA J Med Virol; 1998 Apr; 54(4):285-90. PubMed ID: 9557294 [TBL] [Abstract][Full Text] [Related]
13. Performance of six different commercial assays to demonstrate antibodies to HIV-2 among immigrants from high-endemic areas. Skaug K; Ulstrup JC; Espinoza R Scand J Infect Dis; 1990; 22(3):373-4. PubMed ID: 2371550 [TBL] [Abstract][Full Text] [Related]
14. Differentiation of dual seropositivity to HIV 1 and HIV 2 in Ghanaian sera using line immunoassay (INNOLIA). Mingle JA West Afr J Med; 1997; 16(2):71-4. PubMed ID: 9257539 [TBL] [Abstract][Full Text] [Related]
15. Introduction of human immunodeficiency virus 2 infection into South Korea. Kim SS; Kim EY; Park KY; Suh SD; Park HK; Shin YO; Bae M; Lee JS Acta Virol; 2000 Feb; 44(1):15-22. PubMed ID: 10989687 [TBL] [Abstract][Full Text] [Related]
16. Performance of OraQuick Advance Rapid HIV-1/2 Antibody Test for detection of antibodies in oral fluid and serum/plasma in HIV-1+ subjects carrying different HIV-1 subtypes and recombinant variants. Holguín A; Gutiérrez M; Portocarrero N; Rivas P; Baquero M J Clin Virol; 2009 Jun; 45(2):150-2. PubMed ID: 19451023 [TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of HIV infection in Himachal Pradesh. Thakur TS; Gupta ML; Sharma V; Goyal A J Commun Dis; 1991 Mar; 23(1):38-40. PubMed ID: 1918866 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens. Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590 [TBL] [Abstract][Full Text] [Related]
19. [HIV infection: results of 4 years of observation (May 1984-May 1988)- of the admitting department of the V. Cervello Hospital in Palermo]. Ajello O; Cangelosi C; D'Accardo AM; D'Agostino S; Firaux R; Giardina AR; Majolino I; Marcianò R; Menozzi M; Patti S Ann Ig; 1989; 1(1-2):125-32. PubMed ID: 2483059 [TBL] [Abstract][Full Text] [Related]
20. [Evidence of infection by type 2 (HIV 2) human immunodeficiency virus in heroin addicts in Barcelona]. Soriano V; Tor J; Ribera A; Clotet B; Muga R; Martín J; Foz M Med Clin (Barc); 1989 Sep; 93(6):204-6. PubMed ID: 2601478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]